Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.
Johnson & Johnson Is Exploring Bid for Intra-Cellular Therapies
Estimated read time
1 min read
+ There are no comments
Add yours